Expanded Support for Purdue Pharma's $7.4 Billion Opioid Settlement

A total of 55 state attorneys general have now endorsed a substantial $7.4 billion agreement with Purdue Pharma and its proprietors, the Sackler family, addressing the opioid crisis, as per official announcements.

Initially, 15 states agreed to the terms in January, but that number has expanded significantly. As of now, 34 more states, alongside five territories and Washington, D.C., have joined, confirmed by details from legal representatives handling the case. Oklahoma had previously reached a settlement back in 2019.

Upon judicial approval, this arrangement would terminate the Sacklers’ governance over Purdue, famous for producing OxyContin, a powerful dependency-causing analgesic, and would also prevent their future opioid sales in the United States.

New York Attorney General Letitia James highlighted the grave impact of the Sacklers, stating, "For many years, the Sackler family's pursuit of profit contributed heavily to the wave of opioid dependency and fatalities. Although no financial restitution can undo their harm entirely, these resources will significantly aid in preserving lives and tackling the ongoing opioid epidemic."

Distribution of the funds is planned over a 15-year span, but more than half is allocated for the initial few years. The Sackler family will begin with $1.5 billion, Purdue will contribute approximately $900 million, followed by incremental payments of $500 million, $500 million, and $400 million over the subsequent three years respectively.

Allocations vary across states: California may receive up to $440 million, while Colorado and New Jersey expect around $75 million and $124.5 million respectively. New York anticipates securing up to $250 million.

In a note to CBS News, Purdue expressed that the settlement's proceeds will be employed to recompense those impacted, mitigate the opioid emergency, and distribute opioid use disorder treatments and lifesaving overdose antidotes.

"We acknowledge the intense dedication of the state attorneys general and our additional creditors in reaching this point," the company conveyed.

This agreement results in Purdue undergoing bankruptcy but under monitored supervision, preventing them from opioid advertising or political lobbying. A board of trustees, appointed by participating states, will supervise Purdue and shape its upcoming trajectory.

A prior settlement proposition was invalidated by the Supreme Court last year. In a narrow 5-4 decision, the Court ruled against giving legal immunity to the Sackler family members against civil claims tied to their role in the opioid epidemic, which initially involved a $4.5 billion compensation plan with Purdue.